Capstone Therapeutics Announces Transfer to Nasdaq Capital Market
November 17, 2009 15:47 ET
|
Capstone Therapeutics
TEMPE, Ariz., Nov. 17, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (the "Company") (Nasdaq:CAPS) today announced that its application to transfer the listing of its common stock from The Nasdaq...
Capstone Therapeutics Announces Third Quarter 2009 Financial Results
November 09, 2009 08:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., Nov. 9, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS), trade name of OrthoLogic Corp. (the "Company"), today announced financial results for the third quarter 2009.
The...
Capstone Therapeutics to Host Conference Call Discussing Third Quarter 2009 Operating Results
November 04, 2009 08:00 ET
|
Capstone Therapeutics
TEMPE, Az., Nov. 4, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS), trade name of OrthoLogic Corp. (the "Company"), will host a conference call and webcast presenting third quarter 2009...
Capstone Therapeutics to Present at 4th Annual BIOCOM Investor Conference
October 22, 2009 16:51 ET
|
Capstone Therapeutics
TEMPE, Ariz., Oct. 22, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) is scheduled to make a presentation at the BIOCOM Investor Conference, Hyatt Regency La Jolla (CA) on October 26,...
Capstone Therapeutics Announces Presentation of Chrysalin(R) (TP508) Pre-Clinical Data At the American College of Surgeons 95th Annual Clinical Conference Demonstrating Significant Benefit in a Model of Acute Heart Disease and Elevated Cholesterol
October 13, 2009 15:35 ET
|
Capstone Therapeutics
TEMPE, Ariz., Oct. 13, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) today announced the presentation of pre-clinical data at the American College of Surgeons 95th Annual Clinical...
Capstone Therapeutics Announces Completion of Enrollment for Second of Two AZX100 Phase 2 Studies in Keloid Scarring; Phase 2 Study in Shoulder Surgery Scarring Reaches Enrollment Milestone
September 30, 2009 08:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., Sept. 30, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) announced today the completion of enrollment for the second of its two ongoing AZX100 Phase 2 clinical trials in...
Capstone Therapeutics Announces Second Quarter 2009 Financial Results
August 12, 2009 06:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., Aug. 12, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS), trade name of OrthoLogic Corp. (the "Company"), today announced financial results for the second quarter...
Capstone Therapeutics to Host Conference Call Discussing Second Quarter 2009 Operating Results
August 04, 2009 14:30 ET
|
Capstone Therapeutics
TEMPE, Ariz., Aug. 4, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS), trade name of OrthoLogic Corp. (the "Company") will host a conference call and webcast presenting second quarter...
Capstone Therapeutics Announces Completion of Enrollment for First of Two AZX100 Phase 2 Pilot Studies in Keloid Scarring
July 14, 2009 08:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., July 14, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) announced today the completion of enrollment for the first of its two ongoing AZX100 Phase 2 pilot clinical trials...
Capstone Therapeutics Announces First Quarter 2009 Financial Results
May 11, 2009 06:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., May 11, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS), trade name of OrthoLogic Corp. (the "Company"), today announced financial results for the first quarter 2009.
The...